SALIX PHARMACEUTICALS INC's ticker is SLXP and the CUSIP is 795435106. A total of 245 filers reported holding SALIX PHARMACEUTICALS INC in Q4 2013. The put-call ratio across all filers is 0.94 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2015 | $249,222,000 | -42.7% | 1,442,171 | -61.9% | 0.02% | -45.2% |
Q4 2014 | $434,969,000 | -23.7% | 3,784,309 | +3.7% | 0.03% | -29.5% |
Q3 2014 | $570,079,000 | +18.2% | 3,648,738 | -6.7% | 0.04% | +15.8% |
Q2 2014 | $482,342,000 | +13.0% | 3,910,354 | -5.1% | 0.04% | +5.6% |
Q1 2014 | $426,933,000 | +32.6% | 4,120,577 | +15.1% | 0.04% | +28.6% |
Q4 2013 | $322,052,000 | +37.8% | 3,580,743 | +2.5% | 0.03% | +21.7% |
Q3 2013 | $233,676,000 | +1.1% | 3,493,966 | -0.0% | 0.02% | -4.2% |
Q2 2013 | $231,228,000 | – | 3,495,501 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 467,943 | $30,954,000 | 11.01% |
TANG CAPITAL MANAGEMENT LLC | 300,000 | $19,845,000 | 7.82% |
OAK RIDGE INVESTMENTS LLC | 1,382,895 | $91,478,000 | 2.87% |
SECTOR GAMMA AS | 147,001 | $9,724,000 | 2.84% |
Credo Capital Management, LLC | 38,869 | $2,571,000 | 1.98% |
Cardinal Capital Management | 48,226 | $3,190,000 | 1.89% |
ZEVENBERGEN CAPITAL INVESTMENTS LLC | 626,800 | $41,463,000 | 1.68% |
HERNDON CAPITAL MANAGEMENT LLC | 1,284,472 | $84,967,823,000 | 1.27% |
CATAPULT CAPITAL MANAGEMENT LLC | 45,000 | $2,977,000 | 1.24% |
Pier Capital, LLC | 108,556 | $7,181,000 | 1.10% |